Conversely, in prostate cancer cells, GLCE dysregulation appears to be largely mediated via aberrant GLCE promoter methylation, which varies dramatically between prostate cancer cell types and has been proposed to be a potential contributor to intratumor heterogeneity [120]. Here, GLCE is linked to Familial prostate cancer.